L.s. Rao
Chief Scientific Officer
Drug delivery
Rubicon Research
India
Biography
Dr. Rao has over 35 years of pharmaceutical research experience coupled with regulatory expertise. He has numerous patents and publications in the area of drug delivery systems. Dr Rao had positions of responsibility at Wellcome Foundation (GlaxoSmithKline) at Kent (U.K.). He was also head of Product Development at Indian operations of Burroughs Wellcome (GlaxoSmithKline). During his stint at GlaxoSmithKline he was responsible for various NDA applications including Zovirax and novel liposomal formulations. His most recent assignments included heading scientific affairs at Chauvin Pharmaceuticals Ltd (U.K.) and Smith and Nephew Pharmaceuticals Ltd (U.K.) He is widely regarded as an expert in developing complex dosage forms such as AMETOP®, NODS® (Novel Opthalmic Delivery System), MINIMS® format, development of an aqueous suspension formulation of acyclovir for the treatment of herpes simplex keratitis amongst many others. Dr. Rao is a Fellow of the Royal Society of Chemistry and Member of the British Institute of Regulatory Affairs.
Research Interest
Drug delivery systems
